Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

被引:23
|
作者
de Vries, Paul S. [1 ]
Boender, Johan [2 ]
Sonneveld, Michelle A. H. [2 ,3 ]
Rivadeneira, Fernando [1 ,4 ]
Ikram, M. Arfan [1 ,3 ,5 ]
Rottensteiner, Hanspeter [6 ]
Hofman, Albert [1 ]
Uitterlinden, Andre G. [1 ,4 ]
Leebeek, Frank W. G. [2 ]
Franco, Oscar H. [1 ]
Dehghan, Abbas [1 ]
de Maat, Moniek P. M. [2 ]
机构
[1] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[5] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[6] Baxter Innovat GmbH, Vienna, Austria
关键词
VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; ABO BLOOD-GROUP; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; MISSENSE MUTATION; LOW-FREQUENCY; TRANSCRIPTION; GENOME;
D O I
10.1182/blood-2015-02-629865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (beta, -20.2%; P=1.3 x 10(-33)) and replication sample (P = 3.3 x 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (beta, 3.0; P = 9.6 x 10(-21)) and rs139911703 (beta, -11.6; P=3.6 x 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 x 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (beta, -32.2%; P = 3.7 x 10(-6)), rs142572218 (beta, -46.0%; P = 3.9 x 10(-5)), and rs36222275 (beta, -13.9%; P = 2.9 x 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.
引用
收藏
页码:3949 / 3955
页数:7
相关论文
共 50 条
  • [31] Variability in measurement of ADAMTS13: a UK NEQAS multicentre exercise for ADAMTS13 assays
    Jennings, I.
    Mackie, I.
    Kitchen, S.
    Kitchen, D. P.
    Woods, T. A. L.
    Walker, I. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 35 - 35
  • [32] Variability in measurement of ADAMTS13: a UK NEQAS multicentre exercise for ADAMTS13 assays
    Jennings, I
    Mackie, I. J.
    Fretwell, R.
    Kitchen, S.
    Kitchen, D.
    Woods, T.
    Walker, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 656 - 656
  • [33] A NOVEL ADAMTS13 MUTATION IN A PEDIATRIC PATIENT WITH CONGENITAL AND ACQUIRED ADAMTS13 DEFICIENCY
    Yalcin, K.
    Cairo, A.
    Guler, E.
    Mancini, I.
    Peyvandi, F.
    Kupesiz, A.
    HAEMATOLOGICA, 2016, 101 : 642 - 643
  • [34] ADAMTS13 assays and ADAMTS13-deficient mice
    Miyata, Toshiyuki
    Kokame, Koichi
    Banno, Fumiaki
    Shin, Yongchol
    Akiyama, Masashi
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (03) : 277 - 283
  • [35] Decreased plasma ADAMTS13 antigen and ADAMTS13 activity as a risk factor for hypercoagulability in patients with ulcerative colitis
    Owczarek, D.
    Cibor, D.
    Salapa, K.
    Rodacki, T.
    Domagala-Rodacka, R.
    Mach, T.
    Undas, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S208 - S209
  • [36] ADAMTS13 cleavage of VWF
    Lane, D. A.
    HAEMOPHILIA, 2012, 18 : 107 - 107
  • [37] Hemoglobin versus ADAMTS13
    Motto, D
    BLOOD, 2005, 105 (02) : 436 - 437
  • [38] Intraplatelet localization of ADAMTS13
    Garagiola, I
    Lombardi, R.
    Artoni, A.
    De Cristofaro, R.
    Cattaneo, M.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 347 - 347
  • [39] Transcriptional regulation of ADAMTS13
    Claus, RA
    Bockmeyer, CL
    Kentouche, K
    Sieber, MW
    Oberle, V
    Kaufmann, R
    Deigner, HP
    Lösche, W
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) : 41 - 45
  • [40] ADAMTS13 in thrombotic microangiopathies
    Remuzzi, G
    Galbusera, M
    Mannucci, PM
    BLOOD, 2002, 100 (10) : 3842 - 3842